BasilioColligris, Jesús Pintor
168
Table1.-‐
Drugs andproperties.
Drug
Company
Properties
Phase
AL-‐2178/Rimexolone
Alcon/Novartis
Anti-‐inflammatory Phase III
LX214/Voclosporin
Isotechnika and Lux
Biosciences
Anti-‐inflammatory Phase I
Tofacitinib
Pfizer Inc.
Anti-‐inflammatory Phase II
Nutrilarm®-‐Omega-‐3 and Omega
6 fattyacids
ThéaLaboratoire
Anti-‐inflammatory Phase II
Omega-‐3-‐acidethyl esters
Lovaza,
GlaxoSmithKline
Anti-‐inflammatory Phase I
SecukinumabandCanakinumab
Novartis
Pharmaceuticals
Anti-‐inflammatory Phase II
MIM-‐D3
Mimetogen
Pharmaceuticals
Mucinsecretagogue Phase II
Difluprednate-‐Durezol
Alcon/Novartis
Anti-‐inflammatory Phase II
Cis-‐urocanicacid
LaurantisPharma
Anti-‐inflammatory Phase I
ThymosinBeta4
RegeneRx
Biopharmaceuticals,
Inc.
Anti-‐inflammatory Phase II
Belimumab
UniversityofUdine Anti-‐inflammatory Phase II
Rituximab
IDEC
Pharmaceuticals
Anti-‐inflammatory Phase III
Lotemax
Bausch&LombInc.
Anti-‐inflammatory Phase II
Ecabet sodium
Bausch&LombInc.
Mucinsecretagogue Phase II
BOL-‐303242-‐X(mapracorat)
Bausch&LombInc.
Anti-‐inflammatory Phase II
AL43546
Alcon/Novartis
Artificial tears
Phase II
Sirolimus-‐Rapamycin
Santen
Pharmaceutical
Anti-‐inflammatory
and
immunosuppressive
Phase II
ISV-‐101
InSiteVision
Anti-‐inflammatory Phase II
ESBA-‐105
AlconandESBATech Anti-‐inflammatory Phase II
DA-‐6034
Dong-‐A
Pharmaceutical Co.
Mucinsecretagogue Phase II
RX-‐10045
Resolvyx
Pharmaceuticals
Anti-‐inflammatory Phase II
Tobradex
(tobramycin/
dexamethasone)
Alcon/Novartis
Anti-‐inflammatory Phase I
SYL1001
Sylentis
Lowers
dry-‐eye
relatedpain
Phase II
R932348
Rigel
Pharmaceuticals
Anti-‐inflammatory Phase II
EBI-‐005
Eleven
Biotherapeutics
Anti-‐inflammatory Phase I
